Skip to main content

eClinical Solutions Expands Leadership Team to Accelerate Company’s Rapid Growth Amidst Life Science Industry’s Digital Transformation

Venu Mallarapu named Vice President of Global Strategy and Operations, will help scale the global adoption, market expansion and innovation of eClinical’s modern clinical trial software and services

eClinical Solutions, a global provider of digital clinical software and services, today announced the appointment of Venu Mallarapu as the company’s Vice President of Global Strategy and Operations, a new role for the organization. Mallarapu has over two decades of experience in business and IT advisory, strategic consulting, and relationship and delivery management to global life sciences research and development (R&D) organizations. He will build on the company’s existing platform and service offerings and collaborate with the leadership team, to lead the next phase of eClinical Solutions’ strategic development, as demand for clinical trial technology increases both in the U.S. and internationally.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220615005723/en/

Venu Mallarapu, Vice President of Global Strategy and Operations, eClinical Solutions (Photo: Business Wire)

Venu Mallarapu, Vice President of Global Strategy and Operations, eClinical Solutions (Photo: Business Wire)

According to Grand View Research, the rising prevalence of chronic disease and a growing clinical trials market in developing countries is driving a projected annual compound growth rate (CAGR) of 5.1% through 2027 in the global clinical trial market. Concurrently, VynZ Research predicts eClinical platforms for clinical trials will witness a 14% CAGR between 2020-2025. In a 2022 report by Gartner® titled “Market Guide for Life Science E-Clinical Platforms,” authored by Jeff Smith, Sr. Director Analyst states, “Gartner expects that e-clinical platforms will continue to play a central role in [life science] development organizations.” He continued, “The e-clinical platform provides an opportunity for IT leaders to rethink traditional solution boundaries, optimize trial processes by leveraging prebuilt integrations between various product types and build a platform that is greater than the sum of its parts.”

eClinical Solutions’ elluminate Clinical Data Cloud, the foundation for digital trials, provides a central location for all clinical and operational data, creating a single source of truth across all data sources from ingestion to insights. The platform’s out of the box data connectors, built-in automation, advanced analytics, and self-service access to data from a single location allows value to be recognized faster and enables smarter decision making through the trial lifecycle for top 20, mid-size, and emerging life science companies.

“As the E-clinical platform market grows, we are focused on continuing to stay ahead of the curve and providing life science companies with the most modern clinical trial technology and service capabilities that will drive significant operational efficiencies and meaningful financial results,” said Raj Indupuri, CEO and Co-founder, eClinical Solutions. “We are excited to welcome Venu to our leadership team to accelerate adoption across market segments and help us further our position as global leaders in the industry. His expertise as a leader in digital transformation in life sciences and building global teams at scale that deliver value and growth make him an invaluable addition to our company.”

Among his various responsibilities, Venu will collaborate with the product and engineering teams and provide input into the vision, strategy, and roadmap for the elluminate Clinical Data Cloud. He will also further establish a collaboration framework across onsite and offshore delivery teams and support key strategic partnerships that drive product and services growth.

“The life science industry, and clinical development ecosystem, have tremendous opportunities to innovate, digitize and transform itself. I’m excited about eClinical’s mission of bringing innovative technologies and services to clinical development teams that result in new therapies being available to patients faster,” said Mallarapu. “I’m honored to join eClinical Solutions and help our current and future clients gain even greater value from elluminate and eClinical Data Services by enhancing our first-in-class solutions and services to address evolving industry changes, needs, and expectations.”

Mallarapu joins eClinical Solutions from Cognizant Technology Solutions, a multinational IT services and consulting company, where he served as Senior Director and Global Head of R&D Solutions Group, managing strategic partnerships with platforms vendors. Prior to that role, he served as Director of Technology & Alliances for Navitas Life Sciences (formerly TAKE Solutions, Inc.), a full-service clinical trial contract research organization (CRO), where he was responsible for developing business solutions for R&D, as well as managing and building new strategic partnerships.

To hear more about the opportunities Venu will be focused on at eClinical, listen to this conversation hosted by eClinical CEO Raj Indupuri, and to learn more about the industry experts and innovators that comprise the eClinical Solutions’ leadership team, please visit: https://www.eclinicalsol.com/about/leadership/.

Gartner is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.

About eClinical Solutions

eClinical Solutions helps life sciences organizations around the world accelerate clinical development initiatives with expert data services and the elluminate Clinical Data Cloud – the foundation of digital trials. Together, the elluminate platform and digital data services give clients self-service access to all their data from one centralized location plus advanced analytics that help them make smarter, faster business decisions. Find out more at eclinicalsol.com.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.